Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
Background: Therapeutic treatment options for chronic autoimmune disorders such as multiple sclerosis (MS) rely largely on the use of non-specific immunosuppressive drugs, which are not able to cure the disease. Presently, approaches to induce antigen-specific tolerance as a therapeutic approach; fo...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2021-08-01
|
| Schriftenreihe: | Therapeutic Advances in Chronic Disease |
| Online-Zugang: | https://doi.org/10.1177/20406223211037830 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|